|
0
|
|
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial.
(nature.com)
|
Cui J
…
Wang L
Nature Medicine
2026-07-09
|
#clinical trial
#oncology
#pancreatic cancer
#chemotherapy
#targeted therapy
|
|
0
|
|
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
(nejm.org)
|
Miller JL
…
Roth CL
New England Journal of Medicine
2026-07-09
|
#clinical trial
#obesity
#hypothalamic
#pharmacotherapy
#melanocortin
|
|
0
|
|
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
(nejm.org)
|
Yue D
…
Wang C
New England Journal of Medicine
2026-07-09
|
#lung cancer
#targeted therapy
#alk-inhibitor
#clinical trial
#adjuvant
|
|
0
|
|
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Davids MS
…
Wierda WG
The Lancet
2026-07-09
|
#leukemia
#clinical trial
#lymphoma
#immunotherapy
#pharmacotherapy
|
|
0
|
|
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTE): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
(linkinghub.elsevier.com)
|
Dezza FC
…
Rodriguez-Bano J
The Lancet
2026-07-09
|
#amr
#clinical trial
#bacteraemia
#antibiotic
#enterobacterales
|